Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma

Advances in Therapy
Shiro MizoueKeiji Yoshikawa

Abstract

This study compared the efficacy and safety of adjunctive brimonidine tartrate 0.1% ophthalmic solution (brimonidine) and timolol maleate 0.5% ophthalmic solution (timolol) in prostaglandin analogue (PGA)-treated normal-tension glaucoma (NTG), assessing the non-inferiority of brimonidine in terms of intraocular pressure (IOP) reduction. In this multicenter, randomized, investigator-masked, parallel-group, clinical study, adjunctive brimonidine or timolol was administered twice daily for 12 weeks in eyes with NTG that had been treated with PGA for at least 90 days and required additional treatment despite an IOP of 16 mmHg or less. IOP was measured on at least three visits before add-on therapy (mean baseline IOP), and at weeks 4, 8, and 12 after adjunctive administration. Systolic/diastolic blood pressure, pulse rate, and adverse events (AEs) were recorded at each visit. A total of 152 individuals were enrolled and 128 (84.2%) were eligible for efficacy analyses. IOP in both groups at each visit decreased significantly from baseline (P < 0.001). However, the difference in the change from baseline IOP at week 12 between the brimonidine (-1.05 ± 1.81 mmHg) and timolol (-1.41 ± 1.40 mmHg) groups was 0.36 mmHg (95% confidence inter...Continue Reading

References

Nov 15, 1986·American Journal of Ophthalmology·W L NelsonJ N Kuritsky
Jun 1, 1984·American Journal of Ophthalmology·J Caprioli, G L Spaeth
Oct 1, 1995·Archives of Ophthalmology·A Lee
Feb 13, 2001·Ophthalmology·D R AndersonUNKNOWN Collaborative Normal-Tension Glaucoma Study Group
Aug 23, 2005·Ophthalmology·Tetsuya YamamotoUNKNOWN Tajimi Study Group, Japan Glaucoma Society
Jul 14, 2007·Ophthalmology·M Cristina LeskeUNKNOWN EMGT Group
May 20, 2009·Ophthalmology·Jin-Wei ChengRui-Li Wei
Apr 20, 2010·Japanese Journal of Ophthalmology·Akira AoyamaTetsuya Yamamoto
Jul 29, 2010·Ophthalmology·John H K LiuRobert N Weinreb
Jan 25, 2011·American Journal of Ophthalmology·Theodore KrupinUNKNOWN Low-Pressure Glaucoma Study Group
Aug 19, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Shinya KomoriTetsuya Yamamoto
Jun 27, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Makoto AiharaKazuhiko Unoki
May 18, 2016·European Journal of Pharmacology·Masamichi FukudaHiroshi Sasaki

❮ Previous
Next ❯

Citations

Jan 3, 2020·Current Opinion in Ophthalmology·Sophia Y Wang, Kuldev Singh
Apr 30, 2020·Human & Experimental Toxicology·N Cimolai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.